Sales rise 67.41% to Rs 215.19 crore
Net profit of Astrazeneca Pharma India reported to Rs 29.09 crore in the quarter ended December 2018 as against net loss of Rs 10.35 crore during the previous quarter ended December 2017. Sales rose 67.41% to Rs 215.19 crore in the quarter ended December 2018 as against Rs 128.54 crore during the previous quarter ended December 2017. ParticularsQuarter EndedDec. 2018Dec. 2017% Var.Sales215.19128.54 67 OPM %18.99-8.43 -PBDT44.37-8.08 LP PBT40.59-11.81 LP NP29.09-10.35 LPPowered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
